Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, Hodge DO, Schaff HV, Holmes DR. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008;118:131–9.

Article  PubMed  Google Scholar 

Jensen MK, Prinz C, Horstkotte D, van Buuren F, Bitter T, Faber L, Bundgaard H. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile. Heart. 2013;99:1012–7.

Article  PubMed  Google Scholar 

Lucon A, Palud L, Pavin D, Donal E, Behar N, Leclercq C, Mabo P, Daubert J-C. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Arch Cardiovasc Dis. 2013;106:373–81.

Article  PubMed  Google Scholar 

Veselka J, Krejčí J, Tomašov P, Zemánek D. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population. Eur Heart J. 2014;35:2040–5.

Article  PubMed  Google Scholar 

Fortunato de Cano S, Nicolas Cano M, de Ribamar Costa J, Alves Pinheiro J, de Mattos Bellio, Barretto R, de Souza Costa, Le Bihan D, Abizaid A, Sousa A, Eduardo Sousa J. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2016;88:953–60.

Article  PubMed  Google Scholar 

Liebregts M, Steggerda RC, Vriesendorp PA, van Velzen H, Schinkel AFL, Willems R, van Cleemput J, van den Berg MP, Michels M, ten Berg JM. Long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in the young and the elderly. JACC Cardiovasc Interv. 2016;9:463–9.

Article  PubMed  Google Scholar 

Rigopoulos AG, Seggewiss H. Twenty years of alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Curr Cardiol Rev. 2016;12:285–96.

Article  PubMed  PubMed Central  Google Scholar 

Liebregts M, Faber L, Jensen MK, Vriesendorp PA, Januska J, Krejci J, Hansen PR, Seggewiss H, Horstkotte D, Adlova R, et al. Outcomes of alcohol septal ablation in younger patients with obstructive hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2017;10:1134–43.

Article  PubMed  Google Scholar 

Wojtarowicz A, Kornacewicz-Jach Z. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8) Observation follow-ups taken at a single medical centre. Cardiol J. 2017;24:125–30.

Article  PubMed  Google Scholar 

Nogic J, Koh Y, Bak M, Gooley RP, Meredith IT, McCormick LM. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a 16-year australian single centre experience. Heart Lung Circ. 2018;27:1446–53.

Article  PubMed  Google Scholar 

Aguiar Rosa S, Fiarresga A, Galrinho A, Cacela D, Ramos R, de Sousa L, Gonçalves A, Bernardes L, Patrício L, Branco LM, et al. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center. Rev Port Cardiol. 2019;38:473–80.

Article  PubMed  Google Scholar 

Fifer MA. Choice of septal reduction therapies and alcohol septal ablation. Cardiol Clin. 2019;37:83–93.

Article  PubMed  Google Scholar 

Sorajja P, Ommen SR, Holmes DR, Dearani JA, Rihal CS, Gersh BJ, Lennon RJ, Nishimura RA. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374–80.

Article  PubMed  Google Scholar 

Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle ED, Williams WG. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg. 2005;129:351–8.

Article  PubMed  Google Scholar 

Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol. 2004;44:2329–32.

Article  PubMed  Google Scholar 

Holmes DR, Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv. 2005;66:375–89.

Article  PubMed  Google Scholar 

Runquist LH, Nielsen CD, Killip D, Gazes P, Spencer WH. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2002;90:1020–2.

Article  PubMed  Google Scholar 

El-Jack SS, Nasif M, Blake JW, Dixon SR, Grines CL, O’Neill WW. Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. J Interv Cardiol. 2007;20:73–6.

Article  PubMed  Google Scholar 

Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e783-831.

PubMed  Google Scholar 

Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020;76:e159–240.

Article  PubMed  Google Scholar 

Nishimura RA, Holmes DR. Clinical practice Hypertrophic obstructive cardiomyopathy. N Engl J Med. 2004;350:1320–7.

Article  CAS  PubMed  Google Scholar 

Kern MJ, Holmes DG, Simpson C, Bitar SR, Rajjoub H. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 2002;56:503–7.

Article  PubMed  Google Scholar 

Weissler-Snir A, Dorian P, Rakowski H, Care M, Spears D. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-are there predictors of appropriate therapy? Hear Rhythm. 2021;18:63–70.

Article  Google Scholar 

Jensen MK, Faber L, Liebregts M, Januska J, Krejci J, Bartel T, Cooper RM, Dabrowski M, Hansen PR, Almaas VM, et al. Effect of impaired cardiac conduction after alcohol septal ablation on clinical outcomes: insights from the Euro-ASA registry. Eur Hear Journal Qual Care Clin Outcomes. 2019;5:252–8.

Article  Google Scholar 

Chang SM, Nagueh SF, Spencer WH, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003;42:296–300.

Article  PubMed  Google Scholar 

Karimianpour A, Heizer J, Leaphart D, Rier JD, Shaji S, Ramakrishnan V, Nielsen CD, Fernandes VL, Gold MR. Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool. Catheter Cardiovasc Interv. 2021;98:393–400.

Article  PubMed  Google Scholar 

Matsuda J, Takano H, Morooka M, Imori Y, Nakata J, Kitamura M, Tara S, Tokita Y, Yamamoto T, Takayama M, et al. Relationship between procedural right bundle branch block and 1-year outcome after alcohol septal ablation for hypertrophic obstructive cardiomyopathy - a retrospective study. Circ J. 2021;85:1481–91.

Article  PubMed  Google Scholar 

Reinhard W, Ten Cate FJ, Scholten M, De Laat LE, Vos J. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2004;93:1064–6.

Article  PubMed  Google Scholar 

Chen AA, Palacios IF, Mela T, Yoerger DM, Picard MH, Vlahakes G, Lowry PA, Fifer MA. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006;97:264–9.

Article  PubMed  Google Scholar 

Majewski JP, Lelakowski J. Pacemaker dependency: how should it be defined? Europace. 2018;20:1708.

Article  PubMed  Google Scholar 

Korantzopoulos P, Letsas KP, Grekas G, Goudevenos JA. Pacemaker dependency after implantation of electrophysiological devices. Europace. 2009;11:1151–5.

Article  PubMed  Google Scholar 

Sharma E, Chu AF. Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients. J Interv Card Electrophysiol. 2018;51:77–86.

Article  PubMed  Google Scholar 

Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Bonaventura J, et al. Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol. 2021;333:127–32.

Article  PubMed  Google Scholar 

Kashtanov MG, Rzhannikova AD, Chernyshev SD, Kardapoltsev LV, Idov EM, Berdnikov SV, Kochmasheva VV. Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long-term safety. Catheter Cardiovasc Interv. 2020;95:1212–8.

Article  PubMed  Google Scholar 

Kimmelstiel C, Rowin EJ. Fixed, high-volume alcohol dose for septal ablation: high risk with no benefit. Catheter Cardiovasc Interv. 2020;95:1219–20.

Article  PubMed  Google Scholar 

Sathyamurthy I, Nayak R, Oomman A, Subramanyan K, Kalarical MS, Mao R, Ramachandran P. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up. Indian Heart J. 2014;66:57–63.

Article  CAS  PubMed  Google Scholar